This is a StreetInsider.com Premium Only Page

(INVO) – Company Press Releases

Apr 16, 2024 04:59 PM INVO Reports Fourth Quarter and Full Year 2023 Financial Results

Jan 23, 2024 08:00 AM NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)

Dec 11, 2023 08:00 AM NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal

Dec 6, 2023 09:00 AM NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therap

Nov 28, 2023 09:00 AM INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement

Nov 13, 2023 04:01 PM INVO Reports Record Third Quarter 2023 Financial Results

Nov 10, 2023 09:00 AM NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger

Nov 9, 2023 04:40 PM INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants

Oct 27, 2023 09:00 AM Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday,

Oct 24, 2023 10:08 AM Moore Kuehn Encourages INVO, ESMT, HES, and TGH Investors to Contact Law Firm

Oct 23, 2023 07:30 AM INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company

Oct 11, 2023 09:00 AM INVO to Participate in the Lytham Partners Fall 2023 Investor Conference

Sep 29, 2023 04:05 PM INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS

Sep 28, 2023 12:30 PM INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET

Aug 14, 2023 04:05 PM INVO Reports Second Quarter 2023 Financial Results

Aug 11, 2023 08:00 AM INVO Closes Acquisition of Wisconsin Fertility Institute

Aug 9, 2023 04:15 PM INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

Aug 8, 2023 01:55 PM INVO Bioscience Announces Closing of $4.5 Million Public Offering

Aug 4, 2023 09:00 AM INVO Bioscience Announces Pricing of $4.5 Million Public Offering

Aug 3, 2023 08:00 AM INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value

Jul 27, 2023 09:27 AM INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023

Jun 27, 2023 09:00 AM INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device

May 15, 2023 04:05 PM INVO Reports First Quarter 2023 Financial Results

May 8, 2023 04:15 PM INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

Apr 17, 2023 04:05 PM INVO Reports Fourth Quarter and Full Year 2022 Financial Results

Apr 11, 2023 05:30 PM INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023

Apr 5, 2023 09:00 AM INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek

Mar 30, 2023 05:25 PM INVO Provides Preliminary Update on FY2022 Financial Results

Mar 27, 2023 05:06 PM INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering

Mar 24, 2023 08:00 AM INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market

Mar 20, 2023 09:00 AM INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute

Jan 5, 2023 09:00 AM INVO Bioscience Enters Distribution Agreement for Taiwan

Jan 3, 2023 09:00 AM INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center

Nov 30, 2022 09:30 AM First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology

Nov 14, 2022 04:05 PM INVO Bioscience Reports Third Quarter 2022 Financial Results

Nov 10, 2022 04:15 PM INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

Nov 1, 2022 09:00 AM INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo

Oct 21, 2022 09:00 AM INVOcell Review Published in Current Opinion in Obstetrics and Gynecology

Oct 17, 2022 09:00 AM INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo

Sep 22, 2022 09:00 AM Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly

Aug 25, 2022 09:00 AM INVOcell Launched in Malaysia by Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz

Aug 15, 2022 04:05 PM INVO Bioscience Reports Second Quarter 2022 Financial Results

Aug 4, 2022 04:15 PM INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022

Jul 7, 2022 08:00 AM INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment

May 16, 2022 04:15 PM INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China

May 16, 2022 04:05 PM INVO Bioscience Reports First Quarter 2022 Financial Results

May 9, 2022 04:30 PM INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022

Apr 28, 2022 09:00 AM INVO Celebrates National Infertility Awareness Week at the INVO Center in Atlanta, Georgia

Apr 14, 2022 09:00 AM INVO Selects Kansas City as additional INVO Center Location

Apr 4, 2022 09:00 AM INVO Bioscience to Participate in the Lytham Partners Spring 2022 Investor Conference